Background:

NAA15 is a Protein Coding gene. Auxillary subunit of the N-terminal acetyltransferase A (NatA) complex which displays alpha (N-terminal) acetyltransferase activity. The NAT activity may be important for vascular, hematopoietic and neuronal growth and development. Required to control retinal neovascularization in adult ocular endothelial cells. In complex with XRCC6 and XRCC5 (Ku80), up-regulates transcription from the osteocalcin promoter. Diseases associated with NAA15 include n-terminal acetyltransferase deficiency and gastric cancer. Gene Ontology (GO) annotations related to this gene include poly(A) RNA binding and N-acetyltransferase activity. An important paralog of this gene is NAA16.

Classification:

Primary antibody

Alternative names:

NAA15; GA19; NARG1; NATH; TBDN100; N-alpha-acetyltransferase 15; NatA auxiliary subunit; Gastric cancer antigen Ga19; N-terminal acetyltransferase; NMDA receptor-regulated protein 1; Protein tubedown

Species reactivity:

Human;Mouse

Host:

Rabbit

Isotype:

IgG

Immunogen:

The antiserum was produced against synthesized peptide derived from human NARG1. AA range:221-270

Concentration:

1 mg/ml

Molecular weight:

101272

Applications:

WB, IHC-p, IF, ELISA

Storage:

-20°C for one year

More info:

Email: info@sobekbio.com

Orders:

Email: orders@sobekbio.com